Physician profile
Ashley Suarez
NPI 1841643186
$4,038.23
in general payments reported to CMS, 2019-2025
16 companies · $463 in 2025
The $463 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $656 · 2023: $2,620 · 2024: $299 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,370 · Education: $12.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,370.00 |
| Education | $12.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,527.15 | 2022-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $706.88 | 2022-2024 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $480.98 | 2023-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Janssen Pharmaceuticals, INC | $247.03 | 2023 | Xarelto |
| Acadia Pharmaceuticals INC | $182.96 | 2025 | Daybue |
| Amgen INC. | $145.74 | 2023 | Repatha, Otezla |
| Idorsia Pharmaceuticals US INC | $143.39 | 2023 | Quviviq |
| Alexion Pharmaceuticals, INC. | $120.06 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $116.82 | 2023 | Uptravi, Opsumit |
| Supernus Pharmaceuticals, INC. | $97.09 | 2023 | Qelbree |
| Biogen, INC. | $96.51 | 2022 | |
| Bausch Health US, LLC | $46.05 | 2023 | Aplenzin, Wellbutrin |
| Lilly USA, LLC | $44.34 | 2023-2024 | Jardiance, Mounjaro |
| Intra-Sana Laboratories | $38.68 | 2023 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Novo Nordisk INC | $31.63 | 2023 | Wegovy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $12.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Suarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.